The Board of Directors of Regeneron Pharmaceuticals, Inc. (the "Company") sets high standards for the Company's employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business. To fulfill its responsibilities and to discharge its duty, the Board of Directors follows the procedures and standards that are set forth in these guidelines. These guidelines are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.

Corporate Governance Documents View
Amended and Restated Certificate of Incorporation   PDF   1.3 MB Add to Briefcase
Amended and Restated By-Laws   PDF  239.4 KB Add to Briefcase
Corporate Governance Guidelines   PDF   97.5 KB Add to Briefcase
Guidelines Regarding Director Nominations   PDF   59.9 KB Add to Briefcase


Corporate Compliance Documents View
Code of Business Conduct and Ethics   PDF  135.5 KB Add to Briefcase
Corporate Compliance Program   PDF   58.5 KB Add to Briefcase
California Declaration of Compliance   PDF   64.6 KB Add to Briefcase
Conflicts of Interest Policies and Procedures for Directors   PDF   30.7 KB Add to Briefcase


Board Committee Charters View
Audit Committee   PDF  168.7 KB Add to Briefcase
Compensation Committee   PDF   27.7 KB Add to Briefcase
Corporate Governance Committee   PDF   21.1 KB Add to Briefcase
Technology Committee   PDF   10.9 KB Add to Briefcase


Add to Briefcase = add file to Briefcase
Print Print page     Email Email page

Stock Information

NASDAQ:REGN
$23.17   + 0.69
Sep 2, 2010
11:30 AM ET
Quotes delay at least 20min., by eSignal.
Stock price graph
3 Mo.   6 Mo.   1 Yr.

Shareholder Tools

Featured Report